thirty patients ( 18 women , 12 men ) with permanent or paroxysmal atrial fibrillation were treated with a new antiplatelet drug , ticlopidine , in order to study platelet aggregation behaviour , to see whether the drug prevents thromboembolisms and to observe side-effects over a period of 6 months .
C0040207
ticlopidine
C0040038
thromboembolisms